Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults.

Journal of Alzheimer's Disease : JAD
Wei XuAlzheimer’s Disease Neuroimaging Initiative

Abstract

Higher late-life body mass index (BMI) was associated with reduced risk of Alzheimer's disease (AD), which might be explained by a reverse causal relationship. To investigate whether weight loss was a preclinical manifestation of AD pathologies and could be a predictor of cognitive impairment. A total of 1,194 participants (mean age = 73.2 [range: 54 to 91] years, female = 44.5%) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were grouped according to AD biomarker profile as indicated by amyloid (A) and tau (TN) status and clinical stage by clinical dementia rating (CDR). BMI across the biomarker-defined clinical stages was compared with Bonferroni correction. Pearson correlation analysis was performed to test the relationship between the amyloid change by PET and the BMI change. Multiple regression models were used to explore the influences of amyloid pathologies on BMI change as well as the effects of weight loss on longitudinal changes of global cognitive function. BMI was significantly decreased in AD preclinical stage (amyloid positive [A+] and CDR = 0) and dementia stage (A+/TN+ and CDR = 0.5 or 1), compared with the healthy controls (A-/TN-and CDR = 0, p < 0.005), while no significant differences were observ...Continue Reading

References

Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Sep 28, 2005·Neurology·A S BuchmanD A Bennett
Sep 13, 2006·Archives of Neurology·David K JohnsonJohn C Morris
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 11, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael W WeinerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 11, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·John Q TrojanowskiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jun 12, 2010·Neurobiology of Aging·Liana G ApostolovaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 31, 2010·Journal of Neurochemistry·Gurdeep MarwarhaOthman Ghribi
Jun 21, 2011·Neurobiology of Aging·Michael EwersUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 23, 2011·Neurology·E D VidoniUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 4, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Maria C CarrilloMichael W Weiner
Nov 21, 2013·Current Alzheimer Research·Yian GuYaakov Stern
Jun 17, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Shubhabrata MukherjeeUNKNOWN Alzheimer's Disease Genetics Consortium
Nov 8, 2015·Biochimica Et Biophysica Acta·Makoto Ishii, Costantino Iadecola
Jun 25, 2016·Journal of Alzheimer's Disease : JAD·David C HsuUNKNOWN Harvard Aging Brain Study
Apr 30, 2017·Scientific Reports·Stephan MüllerChristoph Laske
Nov 24, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mika KivimäkiMarkus Jokela
Jan 10, 2018·Scientific Reports·Paul J MeakinMichael L J Ashford
Mar 3, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Oskar HanssonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Nov 14, 2018·American Journal of Physiology. Endocrinology and Metabolism·Joshua A KulasColin K Combs
Nov 30, 2018·EMBO Molecular Medicine·Marc Suárez-CalvetUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 12, 2019·Molecular Neurodegeneration·Marc Suárez-CalvetUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 31, 2019·The Journal of Nutrition, Health & Aging·M MaltaisB Vellas
Jun 4, 2019·Journal of Alzheimer's Disease : JAD·Vineeth ThirunavuBrian A Gordon
Apr 7, 2020·Neurobiology of Aging·Jennifer S RabinUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 26, 2020·Journal of Alzheimer's Disease : JAD·Seung Hoon LeeUNKNOWN KBASE ResearchGroup

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Jena N MoodyAlzheimer’s Disease Neuroimaging Initiative (ADNI)
Brain and nerve = Shinkei kenkyū no shinpo
Kazushi Suzuki
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
Pierpaolo AlongiLuigi M E Grimaldi
© 2021 Meta ULC. All rights reserved